GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Active Biotech AB (OTCPK:ATVBY) » Definitions » Cyclically Adjusted PB Ratio

Active Biotech AB (Active Biotech AB) Cyclically Adjusted PB Ratio : (As of Jun. 02, 2024)


View and export this data going back to 2013. Start your Free Trial

What is Active Biotech AB Cyclically Adjusted PB Ratio?

Note: If the price history is too short, we do not calculate current Cyclically Adjusted PB Ratio for this stock. All the historical data is shown as the company's primary share's data instead.

Shiller PE for Stocks: The True Measure of Stock Valuation


Active Biotech AB Cyclically Adjusted PB Ratio Historical Data

The historical data trend for Active Biotech AB's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Active Biotech AB Cyclically Adjusted PB Ratio Chart

Active Biotech AB Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.86 0.93 0.78 0.70 0.51

Active Biotech AB Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.69 0.65 0.69 0.51 0.72

Competitive Comparison of Active Biotech AB's Cyclically Adjusted PB Ratio

For the Biotechnology subindustry, Active Biotech AB's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Active Biotech AB's Cyclically Adjusted PB Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Active Biotech AB's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Active Biotech AB's Cyclically Adjusted PB Ratio falls into.



Active Biotech AB Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

Active Biotech AB's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2024 is calculated as:

For example, Active Biotech AB's adjusted Book Value per Share data for the three months ended in Mar. 2024 was:

Adj_Book=Book Value per Share/CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=0.015/132.2054*132.2054
=0.015

Current CPI (Mar. 2024) = 132.2054.

Active Biotech AB Quarterly Data

Book Value per Share CPI Adj_Book
201406 0.582 100.432 0.766
201409 0.443 100.161 0.585
201412 0.709 100.225 0.935
201503 0.455 99.950 0.602
201506 0.377 99.995 0.498
201509 0.344 100.228 0.454
201512 0.236 100.276 0.311
201603 0.221 100.751 0.290
201606 0.204 101.019 0.267
201609 0.182 101.138 0.238
201612 0.205 102.022 0.266
201703 0.195 102.022 0.253
201706 0.174 102.752 0.224
201709 0.178 103.279 0.228
201712 0.072 103.793 0.092
201803 0.063 103.962 0.080
201806 0.093 104.875 0.117
201809 0.084 105.679 0.105
201812 0.076 105.912 0.095
201903 0.067 105.886 0.084
201906 0.061 106.742 0.076
201909 0.052 107.214 0.064
201912 0.044 107.766 0.054
202003 0.034 106.563 0.042
202006 0.028 107.498 0.034
202009 0.023 107.635 0.028
202012 0.021 108.296 0.026
202103 0.079 108.360 0.096
202106 0.068 108.928 0.083
202109 0.056 110.338 0.067
202112 0.040 112.486 0.047
202203 0.025 114.825 0.029
202206 0.013 118.384 0.015
202209 0.035 122.296 0.038
202212 0.026 126.365 0.027
202303 0.017 127.042 0.018
202306 0.009 129.407 0.009
202309 0.001 130.224 0.001
202312 0.023 131.912 0.023
202403 0.015 132.205 0.015

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Active Biotech AB  (OTCPK:ATVBY) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


Active Biotech AB Cyclically Adjusted PB Ratio Related Terms

Thank you for viewing the detailed overview of Active Biotech AB's Cyclically Adjusted PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Active Biotech AB (Active Biotech AB) Business Description

Traded in Other Exchanges
Address
Scheelevagen 22, Lund, SWE, 223 63
Active Biotech AB focuses on the research and development of pharmaceuticals products within medical areas including neurodegenerative diseases, autoimmune/inflammatory disease and various forms of cancer. Its project portfolio contains both small molecules that are orally active immunomodulatory agents and antibody based immunotherapy.

Active Biotech AB (Active Biotech AB) Headlines

No Headlines